Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Income from Continuing Operations rose 4775.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 580.51%. This contributed to the annual value of -$10.7 million for FY2024, which is 3039.44% up from last year.
  • Ekso Bionics Holdings' Income from Continuing Operations amounted to -$1.4 million in Q3 2025, which was up 4775.57% from -$4.0 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Income from Continuing Operations peaked at -$1.4 million during Q3 2025, and registered a low of -$4.6 million during Q4 2021.
  • For the 5-year period, Ekso Bionics Holdings' Income from Continuing Operations averaged around -$3.4 million, with its median value being -$3.4 million (2021).
  • Examining YoY changes over the last 5 years, Ekso Bionics Holdings' Income from Continuing Operations showed a top increase of 4775.57% in 2025 and a maximum decrease of 6770.44% in 2025.
  • Ekso Bionics Holdings' Income from Continuing Operations (Quarter) stood at -$4.6 million in 2021, then grew by 1.87% to -$4.5 million in 2022, then rose by 21.92% to -$3.5 million in 2023, then soared by 34.88% to -$2.3 million in 2024, then soared by 37.96% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.5 million during Q1 2025.